日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Targeting RRBP1 reverses immune evasion and enhances immunotherapy efficacy via the CXCL10-CXCR3 axis in bladder cancer

靶向 RRBP1 可通过 CXCL10-CXCR3 轴逆转膀胱癌的免疫逃逸并增强免疫疗法的疗效

Shen, Chengquan; Liu, Changxue; Hu, Ding; Ge, Huaixi; Li, Cheng; Qin, Ruize; Zhao, Xinzhao; Wang, Yonghua; Niu, Haitao

Tumor-intrinsic ENO1 inhibition promotes antitumor immune response and facilitates the efficacy of anti-PD-L1 immunotherapy in bladder cancer.

肿瘤内在的ENO1抑制可促进抗肿瘤免疫反应,并提高抗PD-L1免疫疗法在膀胱癌中的疗效

Shen Chengquan, Liu Jing, Hu Ding, Liu Changxue, Xie Fei, Wang Yonghua

The effectiveness and safety of RC48 alone or in combination with PD-1 inhibitors for locally advanced or metastatic urothelial carcinoma: a multicenter, real-world study

RC48单药或联合PD-1抑制剂治疗局部晚期或转移性尿路上皮癌的有效性和安全性:一项多中心真实世界研究

Ge, Huaixi; Liu, Changxue; Shen, Chengquan; Hu, Ding; Zhao, Xinzhao; Wang, Yanhua; Ge, Huimin; Qin, Ruize; Ma, Xiaocheng; Wang, Yonghua

Combining machine learning and molecular docking to unravel the molecular network of bladder cancer induced by 2-naphthylamine

结合机器学习和分子对接技术,揭示2-萘胺诱导膀胱癌的分子网络。

Qin, Ruize; Li, Cheng; Liu, Changxue; Shen, Chengquan; Hu, Ding; Zhao, Xinzhao; Ge, Huaixi; Zhu, Jianhang; Wang, Yonghua

A feed-forward loop based on aerobic glycolysis and TGF-β between tumor-associated macrophages and bladder cancer cells promoted malignant progression and immune escape.

肿瘤相关巨噬细胞与膀胱癌细胞之间基于有氧糖酵解和 TGF-β 的前馈回路促进了恶性进展和免疫逃逸

Shen Chengquan, Liu Jing, Jiao Wei, Zhang Xuezhou, Zhao Xinzhao, Yang Xuecheng, Wang Yonghua

Development and Validation of an m6A RNA Methylation Regulators-Based Signature for Predicting the Prognosis of Adrenocortical Carcinoma

开发和验证基于m6A RNA甲基化调控因子的特征谱以预测肾上腺皮质癌的预后

Shen, Chengquan; Liu, Jing; Yang, Xiaokun; Jiao, Wei; Wang, Yonghua

Construction of an Immune-Associated Gene-Based Signature in Muscle-Invasive Bladder Cancer

构建肌层浸润性膀胱癌的免疫相关基因特征

Shen, Chengquan; Xu, Ting; Sun, Yefeng; Wang, Liping; Liang, Zhijuan; Niu, Haitao; Jiao, Wei; Wang, Yonghua